Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2003
08/28/2003WO2002000839A3 Statement as to federally sponsored research
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003US20030163223 Programmable insulin pump
08/28/2003US20030163103 Administering drugs using deposits comprising wetting agents and polymer supports
08/28/2003US20030163017 Multi layer radiation delivery balloon
08/28/2003US20030162861 Bioresorbable hydrogel compositions for implantable prostheses
08/28/2003US20030162841 Biocompatible crosslinked polymers
08/28/2003US20030162835 Method of making particles for use in a pharmaceutical composition
08/28/2003US20030162830 3,4-diphenyl-bicyclo(4.3.0)nonyl derivatives
08/28/2003US20030162827 Atorvastatin calcium and a solubilizer in a ratio of 2:2.5-10
08/28/2003US20030162821 Applying topical mixtures of allantoin, emulsifiers and optionally steroids, nonsteroidal antiinflammatory agents, leukotriene antagonists or monoclonal antibodies, to prevent scarring, ulcers or blisters on skins
08/28/2003US20030162816 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
08/28/2003US20030162769 Administering suppository, containing as primary active ingredient calcium antagonist-Diltiazem Hydrochloride
08/28/2003US20030162757 Topically administering estrogen receptor antagonists
08/28/2003US20030162751 Pharmaceutical composition comprising 5' monophosphate ester of riboflavin and solubilized riboflavin
08/28/2003US20030162750 Lyophilizate of lipid complex of water insoluble porphyrins
08/28/2003US20030162748 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162730 Crystal forms of azithromycin
08/28/2003US20030162726 Sugar-free products with improved characteristics
08/28/2003US20030162711 Pharmaceutical formulation
08/28/2003US20030162439 Coaxial connector having detachable locking sleeve
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
08/28/2003US20030161957 Impregnating polymer with active ingredient solution, adding compressed fluid until precipitation of active ingredient caused by compressed fluid antisolvent effect, removing the solvent and compressed fluid; drug delivery
08/28/2003US20030161899 For prophylaxis of inhalation allergic reactions comprising mixture of saturated hydrocarbons having viscosity of greater than 6 mm2/s123n; treatment of atopic rhinitis in the form of "hayfever"
08/28/2003US20030161895 Comprising water, Xanthan gum, Magnesium aluminum silicate, Kaolin, Silicon dioxide, Sodium sulfacetamide, Sodium thiosulfate, Glyceryl stearate, PEG-100 Stearate, Quillaia saponaria extract, Benzyl alcohol, sulfur, high sorption base
08/28/2003US20030161892 Cumin in powder or oil form is blood clotter in combination with unctuous host substance including petroleum jelly, coconut butter and antiseptics
08/28/2003US20030161889 Microspheres having diameter of 1 nanometer to 10 microns comprised of poly(DL-lactide-co-glycolide) as bulk matrix; immunogenic substance comprising Colony Factor Antigen or hepatitis B surface antigen
08/28/2003US20030161888 Pharmaceutical Composition
08/28/2003US20030161886 Particulate composition
08/28/2003US20030161885 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
08/28/2003US20030161884 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/28/2003US20030161883 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
08/28/2003US20030161882 Osmotic delivery system
08/28/2003US20030161881 Solid dose micro implant
08/28/2003US20030161880 Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
08/28/2003US20030161879 Tablets quickly disintegrating in mouth
08/28/2003US20030161878 Pharmaceutical pills having storage stability formed by mixing alendronic acid and/or sodium salts, binders, lubricants and diluents, used for prophylaxis of bone disorders such as osteoporosis
08/28/2003US20030161877 Administering mixtures of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol -3-thione (oltipraz) and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2, 2'-dicarboxylate (DDB) for prophylaxis of liver disorders; nontoxic
08/28/2003US20030161876 Corn starch particles having enzyme resistance when administered in the mouth, formed by mixing binders, solvents, starches and artificial sweeteners, then sieving and drying; time-release agents for glucose; antidiabetic agents
08/28/2003US20030161875 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
08/28/2003US20030161874 Sustained release dosages containing bupropion hydrochloride carriers and optionally binders or coatings; antidepressants
08/28/2003US20030161873 Method for stabilizing preparation
08/28/2003US20030161872 Casings or shells comprising polymers and plasticizers, encapsulating cores containing herbs such as plant extracts, buffered to a pH in which the polymer is insoluble; pills or pharmaceuticals
08/28/2003US20030161871 Intensifying water solubility of vitamin B12 using solubilizers such as complexing agents, liposomes, oils, surfactants, cosolvents or (micro)emulsions; multicompartment drug delivery kits
08/28/2003US20030161870 Dual enhancer composition for topical and transdermal drug delivery
08/28/2003US20030161869 Portable medical equipment comprising drug reservoirs or containers, supports including adhesive layers and drug impervious substrates, used for delivery of high molecular weight drugs such as insulin, calcitionin or vasopressin
08/28/2003US20030161868 Transdermal drug delivery systems having coverings comprising woven polyester layers, acrylic adhesives containing mixtures of ketoprofen and diclofenac
08/28/2003US20030161867 Skin-permeable selective cyclooxygenase-2 inhibitor composition
08/28/2003US20030161846 Oral administration of an emulsion pre-concentrate of a nitrogen oxide-releasing NSAID, a surfactant, and an oil or fat; forms an oil-in-water emulsion with gastrointestinal fluids; side- effect reduction; bioavailability
08/28/2003US20030161843 Production of carrageenan and carrageenan products
08/28/2003US20030161821 Pharmaceutical composition
08/28/2003US20030161793 UV-photostabilized sunscreen compositions comprising dibenzoylmethane/benzophenone compounds
08/28/2003US20030161791 Water-soluble polymer conjugates of retinoic acid
08/28/2003US20030161790 Electrostatically charged nasal application product with increased strength
08/28/2003US20030160353 Process and press for the production of tablets
08/28/2003US20030160068 Apparatus and method for tissue rinse
08/28/2003US20030159953 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
08/28/2003DE29924428U1 New topical composition for treating herpes family viruses, reduces treatment-related erythema but maintains high activity
08/28/2003DE20308636U1 Transdermal plaster, useful for covering selected areas of human skin, comprises a carrier layer whose top surface is provided with a protective layer with a specified minimum opacity
08/28/2003CA2485530A1 Throat spray
08/28/2003CA2477321A1 Absorption enhancing agent
08/28/2003CA2477284A1 Granulation process
08/28/2003CA2476935A1 Drug delivery system for subconjunctival administration of fine particles
08/28/2003CA2476711A1 Process for preparation of an inhalation powder containing a salt of the cgrp antagonist bibn4096
08/28/2003CA2476626A1 Microparticles with adsorbed polypeptide-containing molecules
08/28/2003CA2476621A1 Inhalation powder containing the cgrp antagonist bibn4096 and process for the preparation thereof
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2476380A1 Stable compositions comprising tezacitabine
08/28/2003CA2475923A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003CA2475600A1 Method for producing high-quality hydrophobic licorice extract
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2468631A1 Prostaglandin composition for the treatment of erectile dysfunction
08/28/2003CA2440190A1 Levothyroxine compositions and methods
08/27/2003EP1338638A1 Aggregate-forming agent
08/27/2003EP1338295A1 Systems for remotely controlling medication infusion and analyte monitoring
08/27/2003EP1338288A1 Cellulosic particle for pharmaceutical preparation
08/27/2003EP1338287A1 Method of forming polypeptide particles
08/27/2003EP1338279A1 Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
08/27/2003EP1338276A1 Adhesive preparation for external use
08/27/2003EP1338275A1 Pharmaceutical composition, the use thereof and method for producing said composition
08/27/2003EP1338274A1 Process for preparing a particulate composition
08/27/2003EP1338273A2 Crystalline triamcinolone acetonide produced by a milling process
08/27/2003EP1338272A1 Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
08/27/2003EP1338271A1 Aqeous solution of ascorbic acid
08/27/2003EP1338261A2 Method for producing a partially coated plaster
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337322A1 Method and device for producing lipid vesicles
08/27/2003EP1337284A2 Switchable tackiness coating compositions for ophthalmic implants
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337279A1 Sterilisation of pharmaceuticals
08/27/2003EP1337273A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
08/27/2003EP1337262A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
08/27/2003EP1337260A1 Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337249A1 Compositions and methods for administration of pharmacologically active compounds
08/27/2003EP1337248A1 Methods for treatment of inflammatory diseases
1 ... 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 ... 2991